Evidence map›Paper›PMID 24066160›Full record

ArticlePloS one2013

Colorectal cancers from distinct ancestral populations show variations in BRAF mutation frequency.

Megan C Hanna, Christina Go, Christine Roden, Robert T Jones, Panisa Pochanard, Ahmed Yasir Javed, Awais Javed, Chandrani Mondal, Emanuele Palescandolo, Paul Van Hummelen and 11 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Distinct Driver Pathway Enrichments and a High Prevalence ofInternational journal of molecular sciences · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Clinicopathological Significance ofJournal of Cancer · 2019
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Racial disparity in metabolic regulation of cancer.Frontiers in bioscience (Landmark edition) · 2017
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 7 institutions in 2 countries.

Megan C HannaCenter for Cancer Genome Discovery, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America ; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America ; The Broad Institute, Cambridge, Massachusetts, United States of America.
Christina Go
Christine Roden
Robert T Jones
Panisa Pochanard
Ahmed Yasir Javed
Awais Javed
Chandrani Mondal
Emanuele Palescandolo
Paul Van Hummelen
Charles Hatton
Adam J Bass
Sung Min Chun
Deuk Chae Na
Tae-Im Kim
Se Jin Jang
Raymond U Osarogiagbon
William C Hahn
Matthew Meyerson
Levi A Garraway
Laura E MacConaill
Harvard University · USDana-Farber Cancer Institute · USSkin Cancer Foundation · USUlsan College · KRAsan Medical Center · KRBroad Institute · USUniversity of Ulsan · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has been demonstrated for some cancers that the frequency of somatic oncogenic mutations may vary in ancestral populations. To determine whether key driver alterations might occur at different frequencies in colorectal cancer, we applied a high-throughput genotyping platform (OncoMap) to query 385 mutations across 33 known cancer genes in colorectal cancer DNA from 83 Asian, 149 Black and 195 White patients. We found that Asian patients had fewer canonical oncogenic mutations in the genes tested (60% vs Black 79% (P = 0.011) and White 77% (P = 0.015)), and that BRAF mutations occurred at a higher frequency in White patients (17% vs Asian 4% (P = 0.004) and Black 7% (P = 0.014)). These results suggest that the use of genomic approaches to elucidate the different ancestral determinants harbored by patient populations may help to more precisely and effectively treat colorectal cancer.

Indexed as

Mutation RateAdultAgedAged, 80 and overAsian PeopleBlack PeopleColorectal NeoplasmsFemaleGenotypeHumansMaleMiddle AgedProto-Oncogene Proteins B-rafWhite PeopleYoung AdultProto-Oncogene Proteins B-raf

Identifiers

PMID24066160
PMCPMC3774610
OpenAlexW2163252701

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.